Skip to content
Disclosery

Sofinnova Investments, Inc.

Follow

13F filer, CIK 1631134, Menlo Park, CA

Sofinnova Investments, Inc. reported $1,934,262,135 across 57 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 59.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-096982

Period
2026-06-30
Reported value
$1.93B
Holdings
57
Top 10 weight
59.81%
New
13
Sold out
30

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GMABadded+3,292,954$90.5M
SPTXnew+3,564,871$77.4M
GILDnew+343,100$43.3M
ANABadded+245,283$16.6M
NRIXnew+524,098$12.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AZNexited-456,031-$89.9M
BMYreduced-1,111,751-$64.1M
JAZZreduced-232,986-$56.1M
RAREreduced-1,428,383-$47.7M
UTHRreduced-83,581-$45.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001104659-26-096982, largest first. % of portfolio is the value over $1,872,026,913, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,550,280 shares; 2024Q4: 1,550,280 shares; 2025Q1: 1,550,280 shares; 2025Q2: 1,550,280 shares; 2025Q3: 1,550,280 shares; 2025Q4: 1,550,280 shares; 2026Q1: 1,550,280 shares; 2026Q2: 1,550,280 shares 1,550,280$421M22.48%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,793,987 shares; 2024Q4: 2,793,987 shares; 2025Q1: 2,793,987 shares; 2025Q2: 2,793,987 shares; 2025Q3: 2,793,987 shares; 2025Q4: 2,793,987 shares; 2026Q1: 2,793,987 shares; 2026Q2: 2,793,987 shares 2,793,987$120M6.4%0Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 752,261 shares; 2026Q2: 4,045,215 shares 4,045,215$111M5.94%+3,292,954Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 188,562 shares; 2024Q4: 504,193 shares; 2025Q1: 510,050 shares; 2025Q2: 694,096 shares; 2025Q3: 588,828 shares; 2025Q4: 959,860 shares; 2026Q1: 598,327 shares; 2026Q2: 365,341 shares 365,341$88M4.7%-232,986Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,995,594 shares; 2024Q4: 1,995,594 shares; 2025Q1: 1,995,594 shares; 2025Q2: 1,995,594 shares; 2025Q3: 1,947,579 shares; 2025Q4: 1,904,408 shares; 2026Q1: 1,904,408 shares; 2026Q2: 1,904,408 shares 1,904,408$79.4M4.24%0Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,564,871 shares 3,564,871$77.4M4.14%newTimeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,696,752 shares; 2024Q4: 1,696,752 shares; 2025Q1: 1,696,752 shares; 2025Q2: 1,696,752 shares; 2025Q3: 1,696,752 shares; 2025Q4: 1,696,752 shares; 2026Q1: 1,696,752 shares; 2026Q2: 1,696,752 shares 1,696,752$58.9M3.15%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 83,300 shares; 2026Q1: 3,145,888 shares; 2026Q2: 1,717,505 shares 1,717,505$57.3M3.06%-1,428,383Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,304,901 shares; 2024Q4: 2,304,901 shares; 2025Q1: 2,304,901 shares; 2025Q2: 2,304,901 shares; 2025Q3: 2,293,788 shares; 2025Q4: 2,293,788 shares; 2026Q1: 2,293,788 shares; 2026Q2: 2,293,788 shares 2,293,788$56.2M3%0Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 371,497 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,512,994 shares; 2026Q1: 1,988,721 shares; 2026Q2: 876,970 shares 876,970$50.5M2.7%-1,111,751Timeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 520,678 shares; 2025Q2: 799,253 shares; 2025Q3: 377,066 shares; 2025Q4: 553,095 shares; 2026Q1: 954,309 shares; 2026Q2: 1,036,328 shares 1,036,328$48.2M2.57%+82,019Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 276,678 shares; 2024Q4: 397,428 shares; 2025Q1: 446,839 shares; 2025Q2: 586,010 shares; 2025Q3: 246,966 shares; 2025Q4: 271,394 shares; 2026Q1: 450,096 shares; 2026Q2: 408,027 shares 408,027$45.3M2.42%-42,069Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 774,227 shares; 2025Q1: 418,900 shares; 2025Q2: 1,050,308 shares; 2025Q3: 1,252,312 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 343,100 shares 343,100$43.3M2.32%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 118,513 shares; 2025Q3: 190,626 shares; 2025Q4: 157,641 shares; 2026Q1: 160,070 shares; 2026Q2: 76,489 shares 76,489$41.4M2.21%-83,581Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,265,230 shares; 2024Q4: 823,160 shares; 2025Q1: 2,182,121 shares; 2025Q2: 2,355,505 shares; 2025Q3: 2,127,941 shares; 2025Q4: 1,973,625 shares; 2026Q1: 2,113,551 shares; 2026Q2: 1,035,148 shares 1,035,148$40.1M2.14%-1,078,403Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 379,527 shares; 2024Q4: 491,726 shares; 2025Q1: 175,317 shares; 2025Q2: 93,610 shares; 2025Q3: 393,499 shares; 2025Q4: 12,266 shares; 2026Q1: 212,747 shares; 2026Q2: 160,429 shares 160,429$39.3M2.1%-52,318Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 386,100 shares; 2024Q4: 343,206 shares; 2025Q1: 1,554,304 shares; 2025Q2: 2,240,528 shares; 2025Q3: 2,227,837 shares; 2025Q4: 3,435,542 shares; 2026Q1: 3,630,454 shares; 2026Q2: 3,669,346 shares 3,669,346$37.2M1.99%+38,892Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 772,070 shares; 2024Q4: 1,071,498 shares; 2025Q1: 716,896 shares; 2025Q2: 614,865 shares; 2025Q3: 985,828 shares; 2025Q4: 2,254,161 shares; 2026Q1: 1,633,897 shares; 2026Q2: 1,658,384 shares 1,658,384$36.8M1.97%+24,487Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 676,766 shares; 2024Q4: 746,824 shares; 2025Q1: 788,666 shares; 2025Q2: 778,476 shares; 2025Q3: 436,051 shares; 2025Q4: 1,618,477 shares; 2026Q1: 1,701,904 shares; 2026Q2: 1,720,316 shares 1,720,316$36.5M1.95%+18,412Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,749,455 shares; 2024Q4: 1,069,090 shares; 2025Q1: 2,622,192 shares; 2025Q2: 2,147,795 shares; 2025Q3: 922,695 shares; 2025Q4: 885,121 shares; 2026Q1: 1,131,786 shares; 2026Q2: 925,119 shares 925,119$34.5M1.84%-206,667Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 132,927 shares; 2025Q1: 1,160,033 shares; 2025Q2: 1,032,362 shares; 2025Q3: 254,268 shares; 2025Q4: 287,690 shares; 2026Q1: 248,253 shares; 2026Q2: 493,536 shares 493,536$33.3M1.78%+245,283Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 118,419 shares; 2025Q4: 438,630 shares; 2026Q1: 509,546 shares; 2026Q2: 471,763 shares 471,763$32.9M1.76%-37,783Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 600,302 shares; 2024Q4: 560,723 shares; 2025Q1: 593,403 shares; 2025Q2: 585,532 shares; 2025Q3: 739,876 shares; 2025Q4: 745,169 shares; 2026Q1: 818,328 shares; 2026Q2: 881,299 shares 881,299$30.5M1.63%+62,971Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,037,776 shares; 2025Q2: 1,216,016 shares; 2025Q3: 1,222,263 shares; 2025Q4: 1,096,705 shares; 2026Q1: 923,086 shares; 2026Q2: 945,690 shares 945,690$29.2M1.56%+22,604Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 536,068 shares; 2024Q4: 527,190 shares; 2025Q1: 697,916 shares; 2025Q2: 708,678 shares; 2025Q3: 440,092 shares; 2025Q4: 454,657 shares; 2026Q1: 406,029 shares; 2026Q2: 303,103 shares 303,103$28.7M1.53%-102,926Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 697,133 shares; 2026Q1: 781,982 shares; 2026Q2: 358,568 shares 358,568$20.5M1.1%-423,414Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 73,315 shares; 2026Q2: 148,993 shares 148,993$18.3M0.98%+75,678Timeline
ALCALCON AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 332,520 shares; 2026Q1: 729,972 shares; 2026Q2: 255,824 shares 255,824$17.2M0.92%-474,148Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 286,307 shares; 2024Q4: 256,281 shares; 2025Q1: 304,254 shares; 2025Q2: 313,923 shares; 2025Q3: 104,339 shares; 2025Q4: 156,801 shares; 2026Q1: 346,075 shares; 2026Q2: 158,398 shares 158,398$16.9M0.9%-187,677Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 384,767 shares; 2024Q4: 402,773 shares; 2025Q1: 342,218 shares; 2025Q2: 716,873 shares; 2025Q3: 520,240 shares; 2025Q4: 437,819 shares; 2026Q1: 386,498 shares; 2026Q2: 380,923 shares 380,923$15.5M0.83%-5,575Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 524,098 shares 524,098$12.7M0.68%newTimeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 865,135 shares 865,135$12.5M0.67%newTimeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 344,166 shares; 2026Q2: 255,903 shares 255,903$12M0.64%-88,263Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 565,199 shares 565,199$11.4M0.61%newTimeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 122,998 shares 122,998$11.2M0.6%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 41,352 shares; 2024Q4: 22,752 shares; 2025Q1: 7,485 shares; 2025Q2: 7,312 shares; 2025Q3: 13,553 shares; 2025Q4: 111,010 shares; 2026Q1: 78,320 shares; 2026Q2: 146,239 shares 146,239$10.7M0.57%+67,919Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 104,400 shares; 2026Q2: 500,039 shares 500,039$7.28M0.39%+395,639Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 144,432 shares 144,432$6.35M0.34%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 337,400 shares 337,400$3.91M0.21%newTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 23,100 shares; 2026Q1: 27,591 shares; 2026Q2: 27,591 shares 27,591$3.23M0.17%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 107,391 shares; 2025Q3: 107,391 shares; 2025Q4: 107,391 shares; 2026Q1: 107,391 shares; 2026Q2: 107,391 shares 107,391$2.39M0.13%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,662,550 shares; 2024Q4: 5,471,299 shares; 2025Q1: 5,481,666 shares; 2025Q2: 2,457,352 shares; 2025Q3: 2,427,724 shares; 2025Q4: 304,770 shares; 2026Q1: 364,763 shares; 2026Q2: 364,763 shares 364,763$2.25M0.12%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 157,640 shares; 2025Q2: 15,717 shares; 2025Q3: 172,833 shares; 2025Q4: 125,722 shares; 2026Q1: 63,680 shares; 2026Q2: 6,440 shares 6,440$2.16M0.12%-57,240Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 47,506 shares; 2026Q2: 47,506 shares 47,506$1.59M0.08%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 141,700 shares; 2026Q2: 321,692 shares 321,692$1.47M0.08%+179,992Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 166,667 shares 166,667$1.29M0.07%newTimeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 117,903 shares; 2025Q3: 170,943 shares; 2025Q4: 158,182 shares; 2026Q1: 189,253 shares; 2026Q2: 189,253 shares 189,253$1.1M0.06%0Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,436 shares 32,436$1.05M0.06%newTimeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 204,015 shares; 2026Q2: 32,267 shares 32,267$1.03M0.06%-171,748Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 137,721 shares; 2025Q3: 137,721 shares; 2025Q4: 137,721 shares; 2026Q1: 137,721 shares; 2026Q2: 137,721 shares 137,721$530K0.03%0Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 222,654 shares; 2025Q4: 222,654 shares; 2026Q1: 222,654 shares; 2026Q2: 222,654 shares 222,654$356K0.02%0Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,884 shares; 2025Q4: 31,884 shares; 2026Q1: 31,884 shares; 2026Q2: 31,884 shares 31,884$188K0.01%0Timeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,079 shares 5,079$149K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
RAREULTRAGENYX PHARMACEUTICAL IN COMcall500,000$16.7M+150,000
ISRGINTUITIVE SURGICAL INC COMcall40,000$15.9Mnew
GMEDGLOBUS MED INC Stockcall200,000$15.8Mnew
EXELEXELIXIS INC Stockput254,200$13.8M+2,700

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IWMISHARES TR600,000$149Mput
XBISPDR SERIES TRUST1,050,000$134Mput
AZNASTRAZENECA PLC456,031$89.9Mshares
QQQINVESCO QQQ TR150,000$86.6Mput
IBBISHARES TR475,000$80.2Mput
UTHRUNITED THERAPEUTICS CORP DEL80,300$47.6Mput
BIIBBIOGEN INC229,521$42.1Mshares
CELCCELCUITY INC366,175$41.8Mshares
CELCCELCUITY INC300,000$34.2Mput
AXSMAXSOME THERAPEUTICS INC.200,000$33.8Mput
BBIOBRIDGEBIO PHARMA INC409,183$30.4Mshares
DXCMDEXCOM INC393,576$24.7Mshares
PFEPFIZER INC800,000$22.5Mcall
LQDALIQUIDIA CORPORATION500,000$18.9Mput
XENEXENON PHARMACEUTICALS INC305,216$17.7Mshares
SYKSTRYKER CORPORATION44,480$14.6Mshares
ROIVROIVANT SCIENCES LTD477,995$13.2Mshares
CMPXCOMPASS THERAPEUTICS INC2,056,161$10.9Mshares
ORICORIC PHARMACEUTICALS INC679,578$8.61Mshares
TNGXTANGO THERAPEUTICS INC395,081$8.27Mshares
REPLREPLIMUNE GROUP INC1,015,400$7.77Mcall
AXGNAXOGEN INC210,665$6.98Mshares
CYTKCYTOKINETICS INC91,791$6.05Mshares
HRMYHARMONY BIOSCIENCES HLDGS IN152,695$4.28Mshares
PCVXVAXCYTE INC50,600$2.94Mshares
CMPXCOMPASS THERAPEUTICS INC500,000$2.65Mcall
ESTAESTABLISHMENT LABS HLDGS INC33,930$1.93Mshares
ACADACADIA PHARMACEUTICALS INC78,551$1.75Mshares
SLNOSOLENO THERAPEUTICS INC14,689$492Kshares
ZYMEZYMEWORKS INC1,610$40.3Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-096982 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001104659-26-096982 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001104659-26-062256 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001104659-26-015127 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001104659-25-111551 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001104659-25-078481 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001104659-25-049266 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001104659-25-013863 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001104659-24-117589 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR/A 0001104659-24-090054 Quarter ended 2023-12-312024-08-15acceptance time not in the bulk data set
13F-HR/A 0001104659-24-089526 Quarter ended 2024-03-312024-08-14acceptance time not in the bulk data set
13F-HR 0001104659-24-087771 Quarter ended 2024-06-302024-08-09acceptance time not in the bulk data set
13F-HR 0001104659-24-061728 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001104659-24-015432 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001104659-23-118095 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001104659-23-091230 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001104659-23-058987 Quarter ended 2023-03-312023-05-11acceptance time not in the bulk data set
13F-HR 0001104659-23-020042 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001104659-22-115835 Quarter ended 2022-09-302022-11-08acceptance time not in the bulk data set
13F-HR 0001104659-22-091098 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001104659-22-060547 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001104659-22-022072 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001104659-21-138952 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001104659-21-106048 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001104659-21-066745 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001104659-21-023887 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001104659-20-124556 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001104659-20-094764 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001104659-20-060328 Quarter ended 2020-03-312020-05-13acceptance time not in the bulk data set
13F-HR 0001104659-20-020437 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001104659-19-064122 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001144204-19-039265 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0001144204-19-026474 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR/A 0001144204-19-009466 Quarter ended 2018-12-312019-02-22acceptance time not in the bulk data set
13F-HR 0001144204-19-007829 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR/A 0001144204-18-060047 Quarter ended 2018-06-302018-11-15acceptance time not in the bulk data set
13F-HR 0001144204-18-060046 Quarter ended 2018-09-302018-11-15acceptance time not in the bulk data set
13F-HR 0001144204-18-044317 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001144204-18-028628 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set